⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Form Health Simplifies GLP-1 Coverage Opportunities for Employers with Transparent, Predictable Pricing
businesswire.com
LLY
NVO
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
globenewswire.com
NVO
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab
prnewswire.com
NVO
ShedRx GLP-1 Platform: Pricing, Process, and What Consumers Should Know Before Starting Telehealth Weight Loss
accessnewswire.com
NVO
LLY
Amid Escalating Market Investment, Physicians Forecast Rapid Uptake of Oral Semaglutide Upon Approval in Obesity, According to Spherix Global Insights
globenewswire.com
NVO
LLY
Europe $7.4 Bn Insulin Pen Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2025-2034
globenewswire.com
LLY
MDT
NVO
SNY
BDX
North America $9.2 Bn Insulin Pen Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2025-2034
globenewswire.com
BDX
LLY
MDT
NVO
SNY
New Data from Semaglutide Trials Provides Critical Insights to Guide Next Generation of Therapies Targeting Alzheimer's Pathobiology
prnewswire.com
NVO
National Advertising Division Will Refer Willow Health to State and Federal Regulatory Authorities for its Compounded Semaglutide Product Claims
globenewswire.com
NVO
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight
prnewswire.com
NVO
ULTX
SGMO
PFE
BMN
SNY
CHGC
RHHBY
ALNY
BIIB
BAY
TSEM
CSL
HEMA
LFB
OCT
SOBI
ASC